Science Current Events | Science News | Brightsurf.com
 
Email a Friend Send to a friend
Printer Friendly Print Is bismuth a safe medicine for the treatment peptic ulcer disease?

Is bismuth a safe medicine for the treatment peptic ulcer disease?

January 05, 2009

Bismuth compounds have been used for centuries in medicine. The discovery of H. pylori in 1983 led to renewed interest in bismuth compounds, because these were found to successfully treat the infection in combination with antibiotics. However, in the 1970s bismuth salts, used at high doses for prolonged periods, were found to lead to neurotoxicity. There has been no summary of evidence for the toxicity of bismuth when used for short periods as part of H. pylori eradication therapy.

A research article to be published on December 28, 2008 in the World Journal of Gastroenterology addresses this question. The research team led by Professor Paul Moayyedi from McMaster University, Canada performed a systematic review and meta-analysis to assess the safety of bismuth compounds, when used in a 1 or 2-week course of H. pylori eradication therapy. They examined the risk of adverse events in randomized controlled trials using bismuth compounds as part of H. pylori eradication therapy compared to other regimens.




Thirty-five randomized controlled trials containing over 4500 patients were identified comparing bismuth with placebo or no treatment, or bismuth salts in combination with antibiotics as part of eradication therapy with the same dose and duration of antibiotics alone or in combination with acid suppression. There were no differences in the total number of adverse events with bismuth versus comparison regimen. Individual adverse events were also no more frequent with bismuth, with the exception of dark stools. There were no significant differences detected in the number of adverse events leading to withdrawal of therapy with bismuth versus comparison regimen.

Their results indicated that Bismuth compounds, when used as part of H. pylori eradication therapy, are safe and well-tolerated. The only adverse event occurring more frequently with bismuth compounds was dark stools, which is of little clinical significance.

These results are encouraging, because there have been recent concerns expressed that PPI-based triple therapies for H. pylori do not lead to satisfactory eradication rates, and therefore the use of bismuth containing regimens has been recommended as a potential first line therapy in the recent Maastricht guidelines. Furthermore, there are now new bismuth combinations commercially available. For these reasons it is important to be sure of the safety of bismuth compounds.

World Journal of Gastroenterology




More Bismuth Compound Current Events and Bismuth Compound News Articles
The Chemistry of Heterocyclic Compounds, Heterocyclic Derivatives of Phosphorous, Arsenic, Antimony and Bismuth (Chemistry of Heterocyclic Compounds: A Series Of Monographs) (Volume 1, 2)

The Chemistry of Heterocyclic Compounds, Heterocyclic Derivatives of Phosphorous, Arsenic, Antimony and Bismuth (Chemistry of Heterocyclic Compounds: A Series Of Monographs) (Volume 1, 2)
by Frederick G. Mann (Author), Arnold Weissberger (Author)



  Arsenic, Antimony and Bismuth (Chemistry of Organometallic Compounds)
by George O. Doak (Author), Leon David Freedman (Author)



  ORGANOMETALLIC COMPOUNDS: METHODS OF SYNTHESIS, PHYSICAL CONSTANTS AND CHEMICAL REACTIONS: VOLUME III: COMPOUNDS OF ARSENIC, ANTIMONY, AND BISMUTH: COVERING THE LITERATURE FROM 1937 TO 1964.
by Springer (Germany) (Publisher)



  Organometallic Compounds, Volume 3: Compounds of Arsenic, Antimony and Bismuth, Literature From 1937 to 1959
b



  The heterocyclic derivatives of phosphorus, arsenic, antimony, bismuth, and silicon (The Chemistry of heterocyclic compounds, a series of monographs)
by Frederick George Mann (Author)



  Gmelin: Handbook of Inorganic and Organometallic Chemistry: Sn - Organotin Compounds: Part 19: Organotin-Nitrogen Compounds (Concluded), Organotin-Phosphorus, -Arsenic, -Antimony and Bismuth Compounds
by Springer-Verlag Berlin and Heidelberg GmbH & Co. K (Publisher)

This volume describes mononuclear organotin compounds with bonds between the tin atom and Group 15 elements (N, P, As, Sb, Bi). It continues the coverage of the organotin-nitrogen compounds, started with volume 18 in 1990 which spans a large variety of substances including compounds with additional bonds to hydrogen, Group 16, or Group 17 elements. Another important chapter is devoted to the organotin-phosphorus compounds. The first authentic organotin phosphine was synthesized in 1959. Numerous other Sn-P compounds have subsequently been prepared and characterized. Many of them are interesting with respect to their use as synthons for novel organophosphorus compounds. Decreasing stability in the series Sn-AS, Sn-Sb, and Sn-Bi restrics the number of possible organotin derivatives. To...

  The quantitative nature of the coaction of bismuth and arsenical compounds in the therapy of experimental syphilis
by Norman Martin Clausen (Author)



  Cinchophen derivatives containing arsenic;: Some new types of organic bismuth compounds,
by Herbert Orion Calvery (Author)



The Chemistry of Organic Arsenic, Antimony and Bismuth Compounds

The Chemistry of Organic Arsenic, Antimony and Bismuth Compounds
by Saul Patai (Editor)

The organic synthetic chemistry of the Group V elements, arsenic, antimony and bismuth are dealt with in this volume in the respected Patai series. Internationally known contributors have written chapters on topics such as the analytical, theoretical, environmental and synthetic chemistry of the organometallic compounds of these elements.

  Properties of crystalline bismuth selenide and its use as a Hall effect magnetometer (NASA technical note)
by John A Woollam (Author)



© 2009 BrightSurf.com